StockData
Charles River Laboratories International, Inc. logo

Charles River Laboratories International, Inc. (CRL) stock

CRLNYSEServices-Commercial Physical & Biological ResearchFiscal year ends December 27
Financials through Q2 FY2026, quarter ended Jun 27, 2026Last filing: 10-Q on Nov 4, 2026Score 6/30225% above fair value
$332.16−3.36 (-1.00%)

Close on Nov 17, 2026Market cap $15.86BP/E –Yield –

Charles River Laboratories International r&d expenses

Research and development expenses are spending on new products and technology.

No r&d expenses figures for Charles River Laboratories International

Charles River Laboratories International has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Charles River Laboratories International figures

See a number that looks wrong?